Abstract: Provided is an in-band full-duplex MIMO antenna, which includes: a substrate; and transmission antenna elements and reception antenna elements separately coaxially disposed on the same plane of the substrate, in which the transmission antenna elements have a first polarization characteristic, and the reception antenna elements have a second polarization characteristic different from the first polarization characteristic.

Abstract: Provided are a method for fabricating a human nasal turbinate-derived mesenchymal stem cell-based 3D bioprinted construct, and a use thereof, wherein the human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted construct is advantageous over conventional mesenchymal stem cell-based, 3D bioprinted constructs in that the former can survive and proliferate stably in vitro and/or in vivo and shows high osteogenic differentiation ability as well, therefore is expected to make a great contribution to the practical use of cellular therapeutic agents.

Abstract: A manufacturing method of an LED display is disclosed. The method includes picking up a plurality of LED chips spaced apart at a first interval with a stretchable stamp, spacing apart the plurality of LED chips at a second interval by stretching the stretchable stamp, and transferring the plurality of LED chips to a target substrate.

Abstract: Proposed is an immunity-enhancing composition containing a Syneilesis palmata extract as an active ingredient. The Syneilesis palmata extract activates macrophage phagocytosis, promotes the production of nitric oxide (NO), inducible nitric oxide synthase (iNOS), interleukin-1? (IL-1?), and tumor necrosis factor-? (TNF-?), and induces TLR2/4 stimulation. In addition, the Syneilesis palmata extract exhibits immunity-enhancing activity by activating macrophage autophagy, suggesting that the Syneilesis palmata extract can be applied to a variety of health supplement foods.

Abstract: The present invention relates to a composition, for prevention or treatment of cancer diseases, comprising CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as an active ingredient. It was found that the secretion of extracellular vesicles from cytokine-activated CD4+ T cells increases and the extracellular vesicles enhance proliferation and activity of CD8+ T cells to induce the death of cancer cells, thereby augmenting an anticancer effect. Thus, the present invention provides the CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as a pharmaceutical agent or an immunotherapeutic agent for cancer diseases, and a method for activating CD8+ T cells by using CD4+ T cell-derived extracellular vesicles to prepare CD8+ T cells showing excellent anticancer activity as described above.

Abstract: A method for producing induced pluripotent stem cells by using CRISPR/Cas system is disclosed. The method includes a step of inserting a reprogramming factor by using a CRSPR/Cas system containing in a safe harbor of somatic cells a delivery means including two guides RNAs and a Cas protein-encoding nucleic acid. The method can prevent mutation in an off-target region and integrate a reprogramming factor into an on-target region safely and specifically, and regulates the reprogramming factor with doxycycline to guarantee consistent expression, whereby induced pluripotent stem cells can be effectively produced. In addition, the induced pluripotent stem cells produced by the method exhibit multipotent markers similar to those of human embryonic stem cells and can differentiate into derivatives of all the three germ layers.

Abstract: The present disclosure relates to a serum exosomal SF3B4 marker composition for diagnosing early stage hepatocellular carcinoma for noninvasive in vitro diagnosis, wherein, by analyzing an expression level of SF3B4 in plasma proteins as well as expression of SF3B4 in exosomes present in sera of hepatocellular carcinoma patients, the possibility as the most suitable liquid biopsy marker was identified, and a new noninvasive biomarker with high diagnostic accuracy in early stage hepatocellular carcinoma for which no reliable biomarker exists at this present was discovered. As such, by using exosomes to identify cancer cell genomes and proteomes without biopsy, the exosomes are highly applicable in the future as a diagnostic biomarker that is useful in a disease group with a high risk in the biopsy such as hepatocellular carcinoma.

Abstract: The present invention relates to a chromatic confocal sensor based on a geometrical phase lens, and provides a chromatic confocal sensor that can confirm a height of a specimen and a location of a height measurement point through a configuration of a simple device.

Abstract: A method for recovering high-purity magnesium sulfate includes: a pre-precipitation step of mixing an alkali precipitant and seawater; a concentration step of reacting a precipitate formed in the pre-precipitation step with sulfuric acid, followed by filtering to obtain a first eluate; a first precipitation step of adding ethanol to the first eluate, and then removing a first precipitated solid to obtain a second eluate; and a second precipitation step of precipitating magnesium sulfate solid by further adding ethanol to the second eluate from which the first precipitated solid has been removed.

Abstract: Disclosed are a method and apparatus for processing source data of a synthetic aperture radar in a satellite, including receiving source data generated based on a signal returned after an electronic device steers a beam from a synthetic aperture radar and backscatters, setting a plurality of subswaths after the electronic device parses the source data, storing based on the plurality of subswaths after the electronic device decodes the source data; and generating image data after the electronic device calls the decoded source data in the order of the plurality of subswaths.

Abstract: The present disclosure relates to an openable/closable vertebral endoscopic device. The openable/closable vertebral endoscopic device includes an endoscope body including a working channel for providing an access route of a surgical instrument to a diseased area of a human body, the working channel having an open channel formed by opening a portion of the working channel such that a portion of the surgical instrument inserted into the working channel is exposed to the outside; and a cover member provided on the endoscope body to selectively open or close the open channel of the endoscope body.

Abstract: Provided is a control method for a system for determining a lesion obtained via real-time image. The control method comprises: an endoscope device obtaining a stomach endoscopy image; the endoscope device transmitting the obtained stomach endoscopy image to a server; the server determining a lesion included in the stomach endoscopy image, by inputting the stomach endoscopy image into a first artificial intelligence model; when it is determined that a lesion is detected in the stomach endoscopy image, the server obtaining an image including the lesion and transmitting the image to a database of the server; the server determining the type of the lesion included in the image, by inputting the image into a second artificial intelligence model; and when it is determined that a lesion is detected in the stomach endoscopy image, a display device displaying a UI for guiding the location of the lesion in the stomach endoscopy image.

Abstract: Provided is an electrochemical aptasensor for detecting di(2-ethylhexyl)phthalate (DEHP) with high sensitivity. The electrochemical aptasensor according to the present invention has a low detection limit concentration by improving sensitivity by sensor surface modification using a nano composite and gold nanoflowers, and has high practical applicability of a sensor by monitoring a trace amount of DEHP migrating from a real plastic product by a simple measurement method.

Abstract: A recombinant vector according to an embodiment is for genome editing without inserting a replicon into the plant genome in a T0 generation plant. The recombinant vector includes a geminivirus-based replicon between the sequence of LB (left border) and sequence of RB (right border) of Ti plasmid. A method of genome editing without inserting a replicon into the plant genome in a T0 generation plant according to an embodiment includes transforming a plant cell by inserting a foreign gene to the aforementioned recombinant vector.

Abstract: A method of evaluating quality of graphene using a confocal laser scanning microscope, the method comprising steps of: irradiating with laser light a graphene layer formed on a catalyst layer; detecting a signal of light reflected from the graphene layer; forming a planar image of the graphene layer using the detected optical signal; and analyzing a contrast between graphene and the catalyst layer in the planar image, wherein the graphene layer is continuously formed on the catalyst layer by a roll-to-roll process.

Abstract: An anti-icing honeycomb core composite manufactured by forming an electromagnetic wave absorption layer by using dielectric fiber, molding the electromagnetic wave absorption layer into a honeycomb core structure by using a molded part including a first base, a second base, and an inner block, hardening the honeycomb core structure, and removing the molded part. The molding step includes first stacking, on the first base including a plurality of grooves in which the inner blocks each having a hexagonal column shape are able to be seated, a plurality of the inner blocks and a plurality of the electromagnetic wave absorption layers as the honeycomb core structure so that the electromagnetic wave absorption layer is disposed between the plurality of inner blocks, and second stacking covering the inner blocks and the electromagnetic wave absorption layers stacked on the first base with the second base having the same shape as the first base.

Abstract: The present invention relates to a technology for diagnosing dizziness by testing eye movement (motion), and more particularly, to a method and apparatus for diagnosing dizziness through eye movement measurement based on virtual reality capable of utilizing a commercialized virtual reality device to measure and test eye movement and transmit resultant data, measuring optokinetic nystagmus through movement of various gazing points (objects) generated in virtual reality, and diagnosing dizziness through the measurement, a recording medium storing a program for realizing the same, and a computer program stored in the recording medium.

Abstract: A method and a device for receiving downlink traffic in a communication system supporting multiple links are disclosed. An operation method of a first device includes the steps of: transmitting a traffic indication map (TIM) through a first link from among multiple links; transmitting, through the first link, first information for indicating one or more links through which a data unit stored in the first device is transmitted; and using the one or more links indicated by the first information, so as to transmit the data unit to a second device indicated by the TIM.

Abstract: A bio-sensing device having a photoelectric element is disclosed. The bio-sensing device includes an infrared pulse generator configured to irradiate infrared pulsed light to a target; the photoelectric element configured to receive the infrared pulsed light which has transmitted through the target, and to generate photocurrent based on the received light; and a sensing element configured to measure a magnitude of either a first peak current of the photocurrent corresponding to a leading edge of the infrared pulsed light or a second peak current of the photocurrent corresponding to a trailing edge of the infrared pulsed light, and to analyze the target based on the measurement result.

Abstract: The present invention relates to a composition containing IL-2 or an expression promoter or activator thereof as an active ingredient for prevention or treatment of cancer disease. In the present invention, it was discovered that when treating cancer cells with IL-2, an anticancer effect was enhanced by inhibiting the secretion of cancer cell-derived exosomes and the expression of PD-L1 inducing immune escape of T cells. IL-2 was also discovered to effectuate the anticancer effect directly on cancer cells compared to conventional techniques exhibiting an immune anticancer effect by activating cytotoxic T cells. Thus, IL-2 or an expression promoter or activator thereof can be advantageously used in a composition for prevention or treatment of cancer diseases.